Metraipolis › archive › dc_58da51ee423b

Ebselen, a promising host-directed therapeutic option against Yersinia pseudotuberculosis infection — Europe PMC PMID:41756129

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41756129
DOI
10.3389/fmicb.2026.1749626
License (as archived)
solo-consultazione
Archived
2026-11-05T22:18:47.851Z
SHA-256 of the archived text
6026a56c8726ebb071b226df4603457006a2d2ed3230de5596144ad0aec916a3
Stable URL of this page
https://metraipolis.com/documento/dc_58da51ee423b

How to cite

Ebselen, a promising host-directed therapeutic option against Yersinia pseudotuberculosis infection — Europe PMC PMID:41756129 — Europe PMC (en), https://europepmc.org/article/MED/41756129 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_58da51ee423b (Metraipolis archive dc_58da51ee423b, sha256 6026a56c8726ebb071b226df4603457006a2d2ed3230de5596144ad0aec916a3)
BibTeX
@misc{dc58da51ee423b,
  title = {Ebselen, a promising host-directed therapeutic option against Yersinia pseudotuberculosis infection — Europe PMC PMID:41756129},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41756129},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_58da51ee423b; sha256 6026a56c8726ebb071b226df4603457006a2d2ed3230de5596144ad0aec916a3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41756129. Agents can read the archived copy with the MCP tool read_document.